Dnaprint Genomics Stock Today
PerformanceWeakest
| Odds Of DistressRisky
|
DNAPrint Genomics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of November 2025 and ending today, the 14th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States.. More on DNAPrint Genomics
DNAPrint Genomics cannot be verified against its exchange. It appears that DNAPrint Genomics is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshDNAPrint Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DNAPrint Genomics (DNAG) is traded on OTCCE Exchange in USA and employs 24 people. DNAPrint Genomics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 386.76 K. DNAPrint Genomics conducts business under Biotechnology sector and is part of Health Care industry.
DNAPrint Genomics currently holds about 134.35 K in cash with (5.78 M) of positive cash flow from operations.
Check DNAPrint Genomics Probability Of Bankruptcy
DNAPrint Genomics Historical Income Statement
DNAPrint Stock Against Markets
Try Other Suggestions
DNAPrint Genomics Corporate Management
| FRCPC MD | Ex Officer | Profile | |
| Hector Ruiz | Ex Officer | Profile | |
| Zach Gaskin | Ex Officer | Profile | |
| Shannon Boyd | Ex Officer | Profile | |
| Jatin Patel | Ex Officer | Profile | |
| Lisa Herren | Ex Officer | Profile | |
| Pauline Gula | Ex Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Can Biotechnology industry sustain growth momentum? Does DNAPrint have expansion opportunities? Factors like these will boost the valuation of DNAPrint Genomics. Projected growth potential of DNAPrint fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating DNAPrint Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DNAPrint Genomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DNAPrint Genomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DNAPrint Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.